Chapter/Section Purchase

1 Study Coverage
1.1 Dermatology OTC Medications Product Introduction
1.2 Market by Type
1.2.1 Global Dermatology OTC Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 External Use
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Dermatology OTC Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dermatology OTC Medications Sales Estimates and Forecasts 2017-2028
2.2 Global Dermatology OTC Medications Revenue Estimates and Forecasts 2017-2028
2.3 Global Dermatology OTC Medications Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dermatology OTC Medications Sales by Region
2.4.1 Global Dermatology OTC Medications Sales by Region (2017-2022)
2.4.2 Global Sales Dermatology OTC Medications by Region (2023-2028)
2.5 Global Dermatology OTC Medications Revenue by Region
2.5.1 Global Dermatology OTC Medications Revenue by Region (2017-2022)
2.5.2 Global Dermatology OTC Medications Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dermatology OTC Medications Sales by Manufacturers
3.1.1 Global Top Dermatology OTC Medications Manufacturers by Sales (2017-2022)
3.1.2 Global Dermatology OTC Medications Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dermatology OTC Medications in 2021
3.2 Global Dermatology OTC Medications Revenue by Manufacturers
3.2.1 Global Dermatology OTC Medications Revenue by Manufacturers (2017-2022)
3.2.2 Global Dermatology OTC Medications Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dermatology OTC Medications Revenue in 2021
3.3 Global Dermatology OTC Medications Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dermatology OTC Medications Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dermatology OTC Medications Sales by Type
4.1.1 Global Dermatology OTC Medications Historical Sales by Type (2017-2022)
4.1.2 Global Dermatology OTC Medications Forecasted Sales by Type (2023-2028)
4.1.3 Global Dermatology OTC Medications Sales Market Share by Type (2017-2028)
4.2 Global Dermatology OTC Medications Revenue by Type
4.2.1 Global Dermatology OTC Medications Historical Revenue by Type (2017-2022)
4.2.2 Global Dermatology OTC Medications Forecasted Revenue by Type (2023-2028)
4.2.3 Global Dermatology OTC Medications Revenue Market Share by Type (2017-2028)
4.3 Global Dermatology OTC Medications Price by Type
4.3.1 Global Dermatology OTC Medications Price by Type (2017-2022)
4.3.2 Global Dermatology OTC Medications Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Dermatology OTC Medications Sales by Application
5.1.1 Global Dermatology OTC Medications Historical Sales by Application (2017-2022)
5.1.2 Global Dermatology OTC Medications Forecasted Sales by Application (2023-2028)
5.1.3 Global Dermatology OTC Medications Sales Market Share by Application (2017-2028)
5.2 Global Dermatology OTC Medications Revenue by Application
5.2.1 Global Dermatology OTC Medications Historical Revenue by Application (2017-2022)
5.2.2 Global Dermatology OTC Medications Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dermatology OTC Medications Revenue Market Share by Application (2017-2028)
5.3 Global Dermatology OTC Medications Price by Application
5.3.1 Global Dermatology OTC Medications Price by Application (2017-2022)
5.3.2 Global Dermatology OTC Medications Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dermatology OTC Medications Market Size by Type
6.1.1 North America Dermatology OTC Medications Sales by Type (2017-2028)
6.1.2 North America Dermatology OTC Medications Revenue by Type (2017-2028)
6.2 North America Dermatology OTC Medications Market Size by Application
6.2.1 North America Dermatology OTC Medications Sales by Application (2017-2028)
6.2.2 North America Dermatology OTC Medications Revenue by Application (2017-2028)
6.3 North America Dermatology OTC Medications Market Size by Country
6.3.1 North America Dermatology OTC Medications Sales by Country (2017-2028)
6.3.2 North America Dermatology OTC Medications Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Dermatology OTC Medications Market Size by Type
7.1.1 Europe Dermatology OTC Medications Sales by Type (2017-2028)
7.1.2 Europe Dermatology OTC Medications Revenue by Type (2017-2028)
7.2 Europe Dermatology OTC Medications Market Size by Application
7.2.1 Europe Dermatology OTC Medications Sales by Application (2017-2028)
7.2.2 Europe Dermatology OTC Medications Revenue by Application (2017-2028)
7.3 Europe Dermatology OTC Medications Market Size by Country
7.3.1 Europe Dermatology OTC Medications Sales by Country (2017-2028)
7.3.2 Europe Dermatology OTC Medications Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dermatology OTC Medications Market Size by Type
8.1.1 Asia Pacific Dermatology OTC Medications Sales by Type (2017-2028)
8.1.2 Asia Pacific Dermatology OTC Medications Revenue by Type (2017-2028)
8.2 Asia Pacific Dermatology OTC Medications Market Size by Application
8.2.1 Asia Pacific Dermatology OTC Medications Sales by Application (2017-2028)
8.2.2 Asia Pacific Dermatology OTC Medications Revenue by Application (2017-2028)
8.3 Asia Pacific Dermatology OTC Medications Market Size by Region
8.3.1 Asia Pacific Dermatology OTC Medications Sales by Region (2017-2028)
8.3.2 Asia Pacific Dermatology OTC Medications Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Dermatology OTC Medications Market Size by Type
9.1.1 Latin America Dermatology OTC Medications Sales by Type (2017-2028)
9.1.2 Latin America Dermatology OTC Medications Revenue by Type (2017-2028)
9.2 Latin America Dermatology OTC Medications Market Size by Application
9.2.1 Latin America Dermatology OTC Medications Sales by Application (2017-2028)
9.2.2 Latin America Dermatology OTC Medications Revenue by Application (2017-2028)
9.3 Latin America Dermatology OTC Medications Market Size by Country
9.3.1 Latin America Dermatology OTC Medications Sales by Country (2017-2028)
9.3.2 Latin America Dermatology OTC Medications Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Dermatology OTC Medications Market Size by Type
10.1.1 Middle East and Africa Dermatology OTC Medications Sales by Type (2017-2028)
10.1.2 Middle East and Africa Dermatology OTC Medications Revenue by Type (2017-2028)
10.2 Middle East and Africa Dermatology OTC Medications Market Size by Application
10.2.1 Middle East and Africa Dermatology OTC Medications Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dermatology OTC Medications Revenue by Application (2017-2028)
10.3 Middle East and Africa Dermatology OTC Medications Market Size by Country
10.3.1 Middle East and Africa Dermatology OTC Medications Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dermatology OTC Medications Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Overview
11.3.3 Teva Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Teva Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Johnson & Johnson Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Mylan
11.6.1 Mylan Corporation Information
11.6.2 Mylan Overview
11.6.3 Mylan Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Mylan Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mylan Recent Developments
11.7 Sun Pharmaceutical
11.7.1 Sun Pharmaceutical Corporation Information
11.7.2 Sun Pharmaceutical Overview
11.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sun Pharmaceutical Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sun Pharmaceutical Recent Developments
11.8 Aurobindo
11.8.1 Aurobindo Corporation Information
11.8.2 Aurobindo Overview
11.8.3 Aurobindo Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Aurobindo Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Aurobindo Recent Developments
11.9 Galderma
11.9.1 Galderma Corporation Information
11.9.2 Galderma Overview
11.9.3 Galderma Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Galderma Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Galderma Recent Developments
11.10 CR SANJIU
11.10.1 CR SANJIU Corporation Information
11.10.2 CR SANJIU Overview
11.10.3 CR SANJIU Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 CR SANJIU Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CR SANJIU Recent Developments
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Corporation Information
11.11.2 Dr. Reddy's Overview
11.11.3 Dr. Reddy's Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Dr. Reddy's Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Dr. Reddy's Recent Developments
11.12 Lupin
11.12.1 Lupin Corporation Information
11.12.2 Lupin Overview
11.12.3 Lupin Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Lupin Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Lupin Recent Developments
11.13 Bausch Health
11.13.1 Bausch Health Corporation Information
11.13.2 Bausch Health Overview
11.13.3 Bausch Health Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Bausch Health Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Bausch Health Recent Developments
11.14 Cipla
11.14.1 Cipla Corporation Information
11.14.2 Cipla Overview
11.14.3 Cipla Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Cipla Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Cipla Recent Developments
11.15 Qilu Pharmaceutical
11.15.1 Qilu Pharmaceutical Corporation Information
11.15.2 Qilu Pharmaceutical Overview
11.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Qilu Pharmaceutical Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Qilu Pharmaceutical Recent Developments
11.16 Almirall
11.16.1 Almirall Corporation Information
11.16.2 Almirall Overview
11.16.3 Almirall Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Almirall Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Almirall Recent Developments
11.17 Lingrui
11.17.1 Lingrui Corporation Information
11.17.2 Lingrui Overview
11.17.3 Lingrui Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Lingrui Dermatology OTC Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Lingrui Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dermatology OTC Medications Industry Chain Analysis
12.2 Dermatology OTC Medications Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dermatology OTC Medications Production Mode & Process
12.4 Dermatology OTC Medications Sales and Marketing
12.4.1 Dermatology OTC Medications Sales Channels
12.4.2 Dermatology OTC Medications Distributors
12.5 Dermatology OTC Medications Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dermatology OTC Medications Industry Trends
13.2 Dermatology OTC Medications Market Drivers
13.3 Dermatology OTC Medications Market Challenges
13.4 Dermatology OTC Medications Market Restraints
14 Key Findings in The Global Dermatology OTC Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer